Stocks
Stocks
US stock futures slipped against a backdrop of uncertainty ahead of a key inflation reading.
Trump-selected Fed chair Kevin Warsh may hope the threat of rate hikes is enough. But stocks might gain ground if he does. Past rate-hike cycles can be a guide.
Stocks
Stocks
Even as they were meeting in Switzerland to hammer out a permanent peace deal, the U.S. and Iran had renewed tensions.
Stocks
The health damage of loneliness is similar to heavy smoking and obesity
Stocks
Stocks
Stocks
Stocks
You don't want to wait until you're about to retire to start asking this question.
The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about 3% year-to-date while the broader market grinds higher. The good news for XLV holders: the fund has clawed back roughly 14% over the past year, and the 2026 setup looks meaningfully
“I’m afraid I’m in a bad place.”
There's a big reason this approach could come back to bite you.